Rapamycin in Combination With Low-dose Aracytin in Elderly Acute Myeloid Leukemia Patients

NCT00235560 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: rapamycin

Sponsor

University Hospital, Toulouse

Collaborators

[object Object]